Zoetis to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Zoetis Inc. (NYSE:ZTS), a leading animal health company, is set to participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. The company will be represented by CEO Kristin Peck and CFO Wetteny Joseph, who will engage in a Q&A session with analysts at 1:05 p.m. ET.
Investors and interested parties can access a live audio webcast of the session through the Zoetis investor relations website. A replay of the event will also be made available on the same platform after the conference concludes. This participation underscores Zoetis' commitment to engaging with the financial community and providing insights into its business strategies and market position.
Zoetis Inc. (NYSE:ZTS), una delle principali aziende nel settore della salute animale, parteciperà alla 22ª Conferenza Globale sulla Salute di Morgan Stanley, che si terrà mercoledì 4 settembre 2024. L'azienda sarà rappresentata dal CEO Kristin Peck e dal CFO Wetteny Joseph, che parteciperanno a una sessione di domande e risposte con gli analisti alle 13:05 ET.
Investitori e parti interessate possono accedere a un webcast audio live della sessione attraverso il sito web delle relazioni con gli investitori di Zoetis. Una registrazione dell'evento sarà disponibile sulla stessa piattaforma dopo la conclusione della conferenza. Questa partecipazione sottolinea l'impegno di Zoetis a interagire con la comunità finanziaria e a fornire approfondimenti sulle proprie strategie aziendali e sulla posizione di mercato.
Zoetis Inc. (NYSE:ZTS), una de las principales empresas de salud animal, participará en la 22ª Conferencia Anual Global de Atención Médica de Morgan Stanley el miércoles 4 de septiembre de 2024. La empresa será representada por la CEO Kristin Peck y el CFO Wetteny Joseph, quienes participarán en una sesión de preguntas y respuestas con analistas a las 1:05 p.m. ET.
Los inversores y las partes interesadas pueden acceder a un webcast de audio en vivo de la sesión a través del sitio web de relaciones con inversores de Zoetis. También se pondrá a disposición una repetición del evento en la misma plataforma después de que finalice la conferencia. Esta participación subraya el compromiso de Zoetis de interactuar con la comunidad financiera y proporcionar información sobre sus estrategias comerciales y su posición en el mercado.
Zoetis Inc. (NYSE:ZTS), 주요 동물 건강 회사가 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참석할 예정입니다. 2024년 9월 4일 수요일에 개최됩니다. 회사는 CEO Kristin Peck과 CFO Wetteny Joseph가 참석하여 오후 1시 5분 ET에 애널리스트들과 질의응답 세션에 참여할 예정입니다.
투자자와 관심 있는 이들은 Zoetis 투자자 관계 웹사이트를 통해 세션의 실시간 오디오 웹캐스트에 접근할 수 있습니다. 또한, 컨퍼런스가 끝난 후 같은 플랫폼에서 이벤트의 재녹음도 제공될 것입니다. 이러한 참여는 Zoetis가 금융 커뮤니티와 소통하고 비즈니스 전략 및 시장 위치에 대한 통찰력을 제공하려는 의지를 강조합니다.
Zoetis Inc. (NYSE:ZTS), une entreprise de santé animale de premier plan, participera à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley le mercredi 4 septembre 2024. L'entreprise sera représentée par la PDG Kristin Peck et le CFO Wetteny Joseph, qui participeront à une séance de questions-réponses avec des analystes à 13h05 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire audio en direct de la session via le site des relations investisseurs de Zoetis. Une rediffusion de l'événement sera également disponible sur la même plateforme après la fin de la conférence. Cette participation souligne l'engagement de Zoetis à interagir avec la communauté financière et à fournir des informations sur ses stratégies commerciales et sa position sur le marché.
Zoetis Inc. (NYSE:ZTS), ein führendes Unternehmen im Bereich Tiergesundheit, wird am 22. Morgan Stanley Global Healthcare Conference teilnehmen, die am Mittwoch, den 4. September 2024 stattfindet. Das Unternehmen wird durch CEO Kristin Peck und CFO Wetteny Joseph vertreten, die um 13:05 Uhr ET an einer Fragerunde mit Analysten teilnehmen werden.
Investoren und Interessierte können über die Website für Investor Relations von Zoetis auf einen Live-Audio-Webcast der Sitzung zugreifen. Eine Aufzeichnung der Veranstaltung wird ebenfalls nach Abschluss der Konferenz auf derselben Plattform bereitgestellt. Diese Teilnahme unterstreicht das Engagement von Zoetis, mit der Finanzgemeinschaft in Kontakt zu treten und Einblicke in ihre Geschäftsstrategien und Marktposition zu geben.
- None.
- None.
Investors and other interested parties will be able to access a live audio webcast of the session by visiting http://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20240820834663/en/
Media Contacts:
Jennifer Albano
1-862-399-0810 (o)
jennifer.albano@zoetis.com
Laura Panza
1-973-975-5176 (o)
laura.panza@zoetis.com
Investor Contacts:
Steve Frank
1-973-822-7141 (o)
steve.frank@zoetis.com
Nick Soonthornchai
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source: Zoetis Inc.
FAQ
When is Zoetis (ZTS) participating in the Morgan Stanley Global Healthcare Conference?
Who will represent Zoetis (ZTS) at the Morgan Stanley healthcare conference?
What time is Zoetis (ZTS) scheduled to present at the Morgan Stanley conference?
How can investors access Zoetis' (ZTS) presentation at the Morgan Stanley conference?
Will there be a replay available of Zoetis' (ZTS) Morgan Stanley conference presentation?
